Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Bajaj Finserv Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited8.90454522727.3669
Domestic EquitiesSun Pharmaceutical Industries Limited7.902015223424.2859
Domestic EquitiesApollo Hospitals Enterprise Limited6.19532735519.0404
Domestic EquitiesAurobindo Pharma Limited6.005115281818.4558
Domestic EquitiesPiramal Pharma Limited4.002779531612.3019
Domestic EquitiesEmcure Pharmaceuticals Limited3.90568200212.0035
Domestic EquitiesCipla Limited3.72328642711.4429
Domestic EquitiesNeuland Laboratories Limited3.5954833911.0500
Domestic EquitiesFortis Healthcare Limited3.329812018310.2336
Domestic EquitiesRubicon Research Limited3.326914943210.2249
Domestic EquitiesGlenmark Pharmaceuticals Limited2.8745438238.8343
Domestic EquitiesLupin Limited2.5412362787.8099
Domestic EquitiesIPCA Laboratories Limited2.4159504837.4250
Domestic EquitiesBiocon Limited2.26241895686.9534
Domestic EquitiesZydus Wellness Limited2.16791486236.6628
Domestic EquitiesEternal Limited2.08532342496.4091
Domestic EquitiesPfizer Limited1.9770133146.0760
Domestic EquitiesVijaya Diagnostic Centre Limited1.9252617185.9169
Domestic EquitiesSanofi Consumer Healthcare India Limited1.9156138635.8873
Domestic EquitiesGodrej Consumer Products Limited1.8776500005.7705
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.8592237925.7139
Domestic EquitiesDr. Lal Path Labs Limited1.6160352364.9665
Domestic EquitiesAbbott India Limited1.558817384.7908
Domestic EquitiesShaily Engineering Plastics Limited1.5448248094.7477
Domestic EquitiesMedPlus Health Services Limited1.3427516524.1267
Domestic EquitiesTorrent Pharmaceuticals Limited1.3308103264.0899
Domestic EquitiesMedi Assist Healthcare Services Limited1.30531005904.0115
Domestic EquitiesHindustan Unilever Limited1.2030155813.6974
Domestic EquitiesJubilant Pharmova Limited1.1178349863.4353
Domestic EquitiesTata Consumer Products Limited1.1068300003.4017
Domestic EquitiesRainbow Childrens Medicare Limited1.0925295033.3577
Domestic EquitiesMax Healthcare Institute Limited1.0896350003.3488
Domestic EquitiesEmami Limited1.0198647823.1342
Domestic EquitiesAlembic Pharmaceuticals Limited1.0180399473.1286
Domestic EquitiesAstraZeneca Pharma India Limited0.908932672.7933
Domestic EquitiesKwality Walls (India) Limited **0.0194155810.0595
Total 92.0663 282.9545
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)3.2522 9.9954
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.0209 0.0643
Total 3.2732 10.0597
Derivatives-FuturesMax Healthcare Institute Limited February 2026 Future2.8746918758.8347
Derivatives-FuturesEternal Limited February 2026 Future1.94752182505.9855
Derivatives-FuturesSun Pharmaceutical Industries Limited February 2026 Future-1.8141-35000-5.5755
Total 3.0080 9.2447
Domestic Mutual Funds UnitsBajaj Finserv Money Market Fund-Direct Plan-Growth1.6525421965.0789
Total 1.6525 5.0789
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.